In an attempt to prevent diabetes to take epidemic shape, the University of Iowa researchers have started study on blood sugar control. The study will evaluate the effects of an investigational drug on blood sugar control, when used in combination with other approved medications for diabetes treatment. Type 2 diabetes patients within the age of 18 to 75 are invited to participate.
Participation involves 11 visits to the UI Lipid Research Center over one year. Eligible participants will receive, at no cost, physical exams and electrocardiograms, laboratory evaluation, nutrition and exercise counseling, a glucose meter for home glucose monitoring, and all study medication. Compensation for travel and parking expenses is available.
The study will involve approximately 990 participants at 250 study sites worldwide. The research study is sponsored by Hoffmann-La Roche.
For more information call the center toll-free at 800-887-6917 or 319-384-5046.